Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024

NCT07091734 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT07091734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07091734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
Lead sponsor
University of Michigan
Phase
Phase 2
Overall status
Recruiting
Start date
September 8, 2025
Completion date
September 30, 2029
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lipodystrophy, partial